Evidence map›Paper›PMID 33562311›Full record

ReviewCells2021

The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson's Disease.

Pauline Mencke, Ibrahim Boussaad, Chiara D Romano, Toshimori Kitami, Carole L Linster, Rejko Krüger

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. DJ-1 Serves as a Central Regulator of Diabetes Complications.Current issues in molecular biology · 2025
    Review
  4. Review
  5. Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Nano-structured strategies in combatting neurodegeneration.Frontiers in bioengineering and biotechnology · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Impact of NQO1 dysregulation in CNS disorders.Journal of translational medicine · 2024
    Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Journal of immunology research · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pauline MenckeTranslational Neuroscience, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 4365 Esch-sur-Alzette, Luxembourg.ORCID 0000-0002-5564-0385
Ibrahim BoussaadTranslational Neuroscience, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 4365 Esch-sur-Alzette, Luxembourg.ORCID 0000-0002-3512-3364
Chiara D RomanoBiospecimen Research Group, Integrated Biobank of Luxembourg, Luxembourg Institute of Health (LIH), 3531 Dudelange, Luxembourg.
Toshimori KitamiRIKEN Outpost Laboratory, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 4365 Esch-sur-Alzette, Luxembourg.ORCID 0000-0001-8418-5230
Carole L LinsterEnzymology & Metabolism, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 4365 Esch-sur-Alzette, Luxembourg.
Rejko KrügerTranslational Neuroscience, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 4365 Esch-sur-Alzette, Luxembourg.ORCID 0000-0003-4258-6241
University of Luxembourg · LUCentre Hospitalier de Luxembourg · LU

Funding

European Union's Horizon 2020 research and innovation programme No 692320 (WIDESPREAD; CENTRE-PD)Fond National de Recherche within the PEARL programme FNR/P13/6682797National Centre for Excellence in Research on Parkinson's disease (NCER-PD) programme NCER-PD
6 · The paper itself

Abstract

DJ-1 is a multifunctional protein associated with pathomechanisms implicated in different chronic diseases including neurodegeneration, cancer and diabetes. Several of the physiological functions of DJ-1 are not yet fully understood; however, in the last years, there has been increasing evidence for a potential role of DJ-1 in the regulation of cellular metabolism. Here, we summarize the current knowledge on specific functions of DJ-1 relevant to cellular metabolism and their role in modulating metabolic pathways. Further, we illustrate pathophysiological implications of the metabolic effects of DJ-1 in the context of neurodegeneration in Parkinson´s disease.

Indexed as

GlycolysisHumansMitochondriaMolecular ChaperonesParkinson DiseaseProtein Deglycase DJ-1Reactive Oxygen SpeciesMolecular ChaperonesProtein Deglycase DJ-1Reactive Oxygen SpeciesDJ-1metabolismParkinson´s disease

Identifiers

PMID33562311
PMCPMC7915027
OpenAlexW3127584344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.